Chemours (CC) Accumulated Expenses (2014 - 2026)

Chemours has reported Accumulated Expenses for 13 years, with the latest figure at $683.0 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses rose 16.75% year-over-year to $683.0 million in Q2 2026; TTM through Jun 2026 was $683.0 million, a 16.75% increase from a year earlier, with the FY2025 full-year figure at $506.0 million, up 27.78% from the prior year.
• Accumulated Expenses was $683.0 million for Q2 2026 at Chemours, up from $462.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $1.1 billion in Q4 2023, with the low at $263.0 million in Q2 2022.
• Average Accumulated Expenses over 5 years is $554.2 million, with a median of $454.5 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses surged 253.61% in 2023, then tumbled 62.61% in 2024.
• Over 5 years, Accumulated Expenses stood at $300.0 million in 2022, then jumped by 253.0% to $1.1 billion in 2023, then plunged by 62.61% to $396.0 million in 2024, then gained by 27.78% to $506.0 million in 2025, then surged by 34.98% to $683.0 million in 2026.
• The last three Accumulated Expenses figures came in at $683.0 million (Q2 2026), $462.0 million (Q1 2026), and $506.0 million (Q4 2025), per Business Quant data.